- $141.61m
- $108.39m
- $123.30m
- 95
- 83
- 70
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60.7 | 53.8 | 84.9 | 117 | 123 |
Cost of Revenue | |||||
Gross Profit | 29.2 | 24.1 | 41.2 | 53.4 | 57 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 58.1 | 55 | 76.4 | 106 | 113 |
Operating Profit | 2.55 | -1.22 | 8.46 | 10.7 | 10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.6 | -1.23 | 8.4 | 10.1 | 11 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.32 | -0.895 | 7.28 | 8.46 | 9.34 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.32 | -0.895 | 7.28 | 8.46 | 9.34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.32 | -0.895 | 7.28 | 8.46 | 9.34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.223 | 0.011 | 0.685 | 0.838 | 0.832 |